Franziska Ebertz

620 total citations · 1 hit paper
8 papers, 496 citations indexed

About

Franziska Ebertz is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Franziska Ebertz has authored 8 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 4 papers in Internal Medicine and 1 paper in Surgery. Recurrent topics in Franziska Ebertz's work include Atrial Fibrillation Management and Outcomes (8 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Cardiac Arrhythmias and Treatments (3 papers). Franziska Ebertz is often cited by papers focused on Atrial Fibrillation Management and Outcomes (8 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Cardiac Arrhythmias and Treatments (3 papers). Franziska Ebertz collaborates with scholars based in Germany and United States. Franziska Ebertz's co-authors include Sebastian Werth, Vera Gelbricht, Luise Tittl, Christina Köhler, Franziska Michalski, Sven Pannach, Kurtuluş Şahin, Jan Beyer‐Westendorf, Norbert Weiss and Ulrike Hänsel and has published in prestigious journals such as Blood, European Heart Journal and Thrombosis and Haemostasis.

In The Last Decade

Franziska Ebertz

8 papers receiving 486 citations

Hit Papers

Rates, management, and outcome of rivaroxaban bleeding in... 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry
    2014 311 citations Jan Beyer‐Westendorf, Sven Pannach et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franziska Ebertz Germany 4 469 343 46 37 31 8 496
Vera Gelbricht Germany 6 696 1.5× 497 1.4× 53 1.2× 72 1.9× 47 1.5× 13 751
Ulrike Hänsel Germany 4 357 0.8× 276 0.8× 42 0.9× 35 0.9× 24 0.8× 5 384
Philomeen Kuijer Netherlands 3 282 0.6× 256 0.7× 36 0.8× 45 1.2× 41 1.3× 4 330
Steve Deitelzweig United States 10 456 1.0× 250 0.7× 11 0.2× 16 0.4× 70 2.3× 22 494
Masahiro Tajiri Japan 9 760 1.6× 427 1.2× 23 0.5× 33 0.9× 134 4.3× 13 793
M.J. Kovacs Canada 4 326 0.7× 325 0.9× 35 0.8× 82 2.2× 59 1.9× 5 411
C.V. Damaraju United States 8 335 0.7× 197 0.6× 15 0.3× 13 0.4× 39 1.3× 11 354
Amelie Elsaesser United States 9 306 0.7× 137 0.4× 11 0.2× 23 0.6× 50 1.6× 14 387
Gloria Kayani United Kingdom 8 461 1.0× 168 0.5× 9 0.2× 30 0.8× 106 3.4× 15 503
Svetlana Marx Germany 9 264 0.6× 217 0.6× 58 1.3× 106 2.9× 21 0.7× 15 368

Countries citing papers authored by Franziska Ebertz

Since Specialization
Citations

This map shows the geographic impact of Franziska Ebertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franziska Ebertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franziska Ebertz more than expected).

Fields of papers citing papers by Franziska Ebertz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franziska Ebertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franziska Ebertz. The network helps show where Franziska Ebertz may publish in the future.

Co-authorship network of co-authors of Franziska Ebertz

This figure shows the co-authorship network connecting the top 25 collaborators of Franziska Ebertz. A scholar is included among the top collaborators of Franziska Ebertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franziska Ebertz. Franziska Ebertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ebertz, Franziska, Vera Gelbricht, Franziska Michalski, et al.. (2015). Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Thrombosis and Haemostasis. 113(6). 1247–1257. 115 indexed citations
2.
Ebertz, Franziska, Sebastian Werth, Christina Köhler, et al.. (2014). Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – Final Results of the Prospective Noac Registry (NCT01588119). Blood. 124(21). 1541–1541. 3 indexed citations
3.
Beyer‐Westendorf, Jan, Sven Pannach, Franziska Ebertz, et al.. (2014). Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry. Blood. 124(6). 955–962. 311 indexed citations breakdown →
4.
Beyer‐Westendorf, Jan, Vera Gelbricht, Franziska Ebertz, et al.. (2014). Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care – results from the Dresden NOAC registry. British Journal of Clinical Pharmacology. 78(4). 908–917. 47 indexed citations
5.
Beyer‐Westendorf, Jan, Franziska Ebertz, Vera Gelbricht, et al.. (2014). Drug Persistence with Rivaroxaban Therapy in Atrial Fibrillation Patients Results from the Dresden NOAC registry. Blood. 124(21). 4264–4264. 2 indexed citations
6.
Ebertz, Franziska, Vera Gelbricht, Luise Tittl, et al.. (2013). Pattern and Management Of Bleeding Complications With Novel Oral Anticoagulants – Results Of The Prospective Dresden Noac Registry (NCT01588119). Blood. 122(21). 214–214. 1 indexed citations
7.
Beyer‐Westendorf, Jan, Vera Gelbricht, Kathrin I. Foerster, et al.. (2013). Periinterventional management of novel oral anticoagulants: results of the prospective Dresden NOAC registry. European Heart Journal. 34(suppl 1). P5444–P5444. 2 indexed citations
8.
Beyer‐Westendorf, Jan, Franziska Ebertz, Vera Gelbricht, et al.. (2013). Real life efficacy and safety of rivaroxaban for stroke prevention in atrial fibrillation: updated results of the prospective NOAC registry (NCT01588119). European Heart Journal. 34(suppl 1). P4870–P4870. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vera Gelbricht Breakdown of academic impact, for papers by Ulrike Hänsel Breakdown of academic impact, for papers by Philomeen Kuijer Breakdown of academic impact, for papers by Steve Deitelzweig Breakdown of academic impact, for papers by Masahiro Tajiri Breakdown of academic impact, for papers by M.J. Kovacs Breakdown of academic impact, for papers by C.V. Damaraju Breakdown of academic impact, for papers by Amelie Elsaesser Breakdown of academic impact, for papers by Gloria Kayani Breakdown of academic impact, for papers by Svetlana Marx
Rankless by CCL
2026